311 related articles for article (PubMed ID: 15342452)
1. Plasma vitamin D metabolites and risk of colorectal cancer in women.
Feskanich D; Ma J; Fuchs CS; Kirkner GJ; Hankinson SE; Hollis BW; Giovannucci EL
Cancer Epidemiol Biomarkers Prev; 2004 Sep; 13(9):1502-8. PubMed ID: 15342452
[TBL] [Abstract][Full Text] [Related]
2. A nested case control study of plasma 25-hydroxyvitamin D concentrations and risk of colorectal cancer.
Wu K; Feskanich D; Fuchs CS; Willett WC; Hollis BW; Giovannucci EL
J Natl Cancer Inst; 2007 Jul; 99(14):1120-9. PubMed ID: 17623801
[TBL] [Abstract][Full Text] [Related]
3. Plasma 25-Hydroxyvitamin D, Vitamin D Binding Protein, and Risk of Colorectal Cancer in the Nurses' Health Study.
Song M; Konijeti GG; Yuan C; Ananthakrishnan AN; Ogino S; Fuchs CS; Giovannucci EL; Ng K; Chan AT
Cancer Prev Res (Phila); 2016 Aug; 9(8):664-72. PubMed ID: 27246684
[TBL] [Abstract][Full Text] [Related]
4. Plasma 1,25-dihydroxy- and 25-hydroxyvitamin D and adenomatous polyps of the distal colorectum.
Platz EA; Hankinson SE; Hollis BW; Colditz GA; Hunter DJ; Speizer FE; Giovannucci E
Cancer Epidemiol Biomarkers Prev; 2000 Oct; 9(10):1059-65. PubMed ID: 11045788
[TBL] [Abstract][Full Text] [Related]
5. Plasma vitamin D and risk of colorectal cancer: the Japan Public Health Center-Based Prospective Study.
Otani T; Iwasaki M; Sasazuki S; Inoue M; Tsugane S;
Br J Cancer; 2007 Aug; 97(3):446-51. PubMed ID: 17622244
[TBL] [Abstract][Full Text] [Related]
6. Circulating vitamin D metabolites, polymorphism in vitamin D receptor, and colorectal adenoma risk.
Peters U; Hayes RB; Chatterjee N; Shao W; Schoen RE; Pinsky P; Hollis BW; McGlynn KA;
Cancer Epidemiol Biomarkers Prev; 2004 Apr; 13(4):546-52. PubMed ID: 15066918
[TBL] [Abstract][Full Text] [Related]
7. Circulating Vitamin D Levels and Risk of Colorectal Cancer in Women.
Chandler PD; Buring JE; Manson JE; Giovannucci EL; Moorthy MV; Zhang S; Lee IM; Lin JH
Cancer Prev Res (Phila); 2015 Aug; 8(8):675-82. PubMed ID: 25813525
[TBL] [Abstract][Full Text] [Related]
8. Low plasma adiponectin levels and risk of colorectal cancer in men: a prospective study.
Wei EK; Giovannucci E; Fuchs CS; Willett WC; Mantzoros CS
J Natl Cancer Inst; 2005 Nov; 97(22):1688-94. PubMed ID: 16288122
[TBL] [Abstract][Full Text] [Related]
9. Dose-response of serum 25-hydroxyvitamin D in association with risk of colorectal cancer: A meta-analysis.
Garland CF; Gorham ED
J Steroid Biochem Mol Biol; 2017 Apr; 168():1-8. PubMed ID: 27993551
[TBL] [Abstract][Full Text] [Related]
10. Association between pre-diagnostic circulating vitamin D concentration and risk of colorectal cancer in European populations:a nested case-control study.
Jenab M; Bueno-de-Mesquita HB; Ferrari P; van Duijnhoven FJ; Norat T; Pischon T; Jansen EH; Slimani N; Byrnes G; Rinaldi S; Tjønneland A; Olsen A; Overvad K; Boutron-Ruault MC; Clavel-Chapelon F; Morois S; Kaaks R; Linseisen J; Boeing H; Bergmann MM; Trichopoulou A; Misirli G; Trichopoulos D; Berrino F; Vineis P; Panico S; Palli D; Tumino R; Ros MM; van Gils CH; Peeters PH; Brustad M; Lund E; Tormo MJ; Ardanaz E; Rodríguez L; Sánchez MJ; Dorronsoro M; Gonzalez CA; Hallmans G; Palmqvist R; Roddam A; Key TJ; Khaw KT; Autier P; Hainaut P; Riboli E
BMJ; 2010 Jan; 340():b5500. PubMed ID: 20093284
[TBL] [Abstract][Full Text] [Related]
11. The influence of health and lifestyle characteristics on the relation of serum 25-hydroxyvitamin D with risk of colorectal and breast cancer in postmenopausal women.
Neuhouser ML; Manson JE; Millen A; Pettinger M; Margolis K; Jacobs ET; Shikany JM; Vitolins M; Adams-Campbell L; Liu S; LeBlanc E; Johnson KC; Wactawski-Wende J
Am J Epidemiol; 2012 Apr; 175(7):673-84. PubMed ID: 22362582
[TBL] [Abstract][Full Text] [Related]
12. Circulating 25-Hydroxyvitamin D Concentration and Risk of Breast, Prostate, and Colorectal Cancers: The Melbourne Collaborative Cohort Study.
Heath AK; Hodge AM; Ebeling PR; Eyles DW; Kvaskoff D; Buchanan DD; Giles GG; Williamson EJ; English DR
Cancer Epidemiol Biomarkers Prev; 2019 May; 28(5):900-908. PubMed ID: 30842127
[TBL] [Abstract][Full Text] [Related]
13. Plasma 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D and risk of breast cancer.
Bertone-Johnson ER; Chen WY; Holick MF; Hollis BW; Colditz GA; Willett WC; Hankinson SE
Cancer Epidemiol Biomarkers Prev; 2005 Aug; 14(8):1991-7. PubMed ID: 16103450
[TBL] [Abstract][Full Text] [Related]
14. Plasma 25-hydroxyvitamin D levels and the risk of colorectal cancer: the multiethnic cohort study.
Woolcott CG; Wilkens LR; Nomura AM; Horst RL; Goodman MT; Murphy SP; Henderson BE; Kolonel LN; Le Marchand L
Cancer Epidemiol Biomarkers Prev; 2010 Jan; 19(1):130-4. PubMed ID: 20056631
[TBL] [Abstract][Full Text] [Related]
15. Circulating levels of vitamin D and colorectal adenoma: A case-control study and a meta-analysis.
Choi YJ; Kim YH; Cho CH; Kim SH; Lee JE
World J Gastroenterol; 2015 Aug; 21(29):8868-77. PubMed ID: 26269676
[TBL] [Abstract][Full Text] [Related]
16. Serum vitamin D, vitamin D binding protein, and risk of colorectal cancer.
Anic GM; Weinstein SJ; Mondul AM; Männistö S; Albanes D
PLoS One; 2014; 9(7):e102966. PubMed ID: 25036524
[TBL] [Abstract][Full Text] [Related]
17. Plasma 1,25-dihydroxy- and 25-hydroxyvitamin D and subsequent risk of prostate cancer.
Platz EA; Leitzmann MF; Hollis BW; Willett WC; Giovannucci E
Cancer Causes Control; 2004 Apr; 15(3):255-65. PubMed ID: 15090720
[TBL] [Abstract][Full Text] [Related]
18. Plasma vitamin B6 and the risk of colorectal cancer and adenoma in women.
Wei EK; Giovannucci E; Selhub J; Fuchs CS; Hankinson SE; Ma J
J Natl Cancer Inst; 2005 May; 97(9):684-92. PubMed ID: 15870439
[TBL] [Abstract][Full Text] [Related]
19. Serum 25-hydroxyvitamin D, vitamin D binding protein and risk of colorectal cancer in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial.
Weinstein SJ; Purdue MP; Smith-Warner SA; Mondul AM; Black A; Ahn J; Huang WY; Horst RL; Kopp W; Rager H; Ziegler RG; Albanes D
Int J Cancer; 2015 Mar; 136(6):E654-64. PubMed ID: 25156182
[TBL] [Abstract][Full Text] [Related]
20. Plasma 25-hydroxyvitamin D and colorectal cancer risk according to tumour immunity status.
Song M; Nishihara R; Wang M; Chan AT; Qian ZR; Inamura K; Zhang X; Ng K; Kim SA; Mima K; Sukawa Y; Nosho K; Fuchs CS; Giovannucci EL; Wu K; Ogino S
Gut; 2016 Feb; 65(2):296-304. PubMed ID: 25591978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
